Cassandra J. Vandenberg
- Oncology top 5%
- Cancer-related Molecular Pathways 9
- PARP inhibition in cancer therapy 5
- CAR-T cell therapy research 5
- Molecular Biology top 5%
- Cell death mechanisms and regulation 13
- Ubiquitin and proteasome pathways 7
- DNA Repair Mechanisms 5
- RNA Interference and Gene Delivery 4
- Hematology top 5%
- Immunology top 5%
- Immune Cell Function and Interaction 5
- Genetics top 5%
- Co-authors
- Suzanne CoryClare L. ScottAndrew W. RobertsDavid C.S. HuangAndrew H. WeiKylie D. MasonJerry M. AdamsAndreas Strasser
- Cited by
- OncologyMolecular BiologyHematology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Nature Medicine (1 paper)Nature Communications (1 paper)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Cassandra J. Vandenberg
43 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 912
- Molecular Biology 2.2k
- Hematology 301
- Immunology 553
- Genetics 268
Countries citing papers authored by Cassandra J. Vandenberg
This map shows the geographic impact of Cassandra J. Vandenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cassandra J. Vandenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cassandra J. Vandenberg more than expected).
Fields of papers citing papers by Cassandra J. Vandenberg
This network shows the impact of papers produced by Cassandra J. Vandenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cassandra J. Vandenberg. The network helps show where Cassandra J. Vandenberg may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cassandra J. Vandenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 1 | |
| 3 | 2021 | 11 | |
| 4 | Chaperone-mediated protein degradation (CHAMP): A novel technology for tumor-targeted protein degradation. | 2021 | 2 |
| 5 | 2020 | 9 | |
| 6 | 2020 | 25 | |
| 7 | SRA737, a novel Chk1 inhibitor, shows efficacy in CCNE1-amplified and MYCN-overexpressing high-grade serous ovarian cancer patient-derived xenograft models | 2018 | 1 |
| 8 | 2018 | 15 | |
| 9 | 2018 | 119 | |
| 10 | 2017 | 11 | |
| 11 | 2016 | 17 | |
| 12 | 2016 | 35 | |
| 13 | 2016 | 6 | |
| 14 | 2015 | 62 | |
| 15 | 2015 | 30 | |
| 16 | 2014 | 131 | |
| 17 | 2014 | 14 | |
| 18 | The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralizedbreakdown → | 2006 | 1008 |
| 19 | 2003 | 107 | |
| 20 | 2002 | 4 |
About Cassandra J. Vandenberg
Cassandra J. Vandenberg is a scholar working on Oncology, Immunology and Molecular Biology, having authored 44 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (13 papers), Cancer-related Molecular Pathways (9 papers), Ubiquitin and proteasome pathways (7 papers), DNA Repair Mechanisms (5 papers), PARP inhibition in cancer therapy (5 papers), CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (5 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Oncology (912 citations), Molecular Biology (2.2k citations) and Hematology (301 citations). Cassandra J. Vandenberg has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Suzanne Cory, Clare L. Scott, Andrew W. Roberts, David C.S. Huang, Andrew H. Wei, Kylie D. Mason, Jerry M. Adams, Andreas Strasser, Peter E. Czabotar and Simon N. Willis. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.